The incidence of venous thromboembolism (VTE) is more than 1‰ annually in the general
population and increases further in cancer patients. The risk of VTE is higher in multiple …

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities
across the globe on an unprecedented scale. Patients have had diverse clinical outcomes …

Background Patients with acute medical illnesses are at prolonged risk for venous
thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown …

Background Patients who are hospitalized for medical illness remain at risk for venous
thromboembolism after discharge, but the role of extended thromboprophylaxis in the …

Background This guideline addressed VTE prevention in hospitalized medical patients,
outpatients with cancer, the chronically immobilized, long-distance travelers, and those with …

Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical
patients is largely underused. We sought to assess the value of a simple risk assessment …

Background The clinically appropriate duration of thromboprophylaxis in hospitalized
patients with acute medical illnesses is unknown. In this multicenter, randomized, double …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Background Acutely ill hospitalized medical patients are at risk for VTE. We assessed the
incidence of VTE in the observational International Medical Prevention Registry on Venous …

Background Information about the variation in the risk for venous thromboembolism (VTE)
and in prophylaxis practices around the world is scarce. The ENDORSE (Epidemiologic …